insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 US$
arrow_downward
-4,09%(-0,070) 1D
1,66 US$
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 US$
High
1,78 US$
Low
1,63 US$
Mkt. cap
253,12 მლნ.
Avg. vol.
2,24 მლნ.
Volume
2,68 მლნ.
52-wk high
3,94 US$
52-wk low
1,63 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,69 US$
High
1,78 US$
Low
1,63 US$
Mkt. cap
253,12 მლნ.
Avg. vol.
2,24 მლნ.
Volume
2,68 მლნ.
52-wk high
3,94 US$
52-wk low
1,63 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
Blockonomi
·
49 წუთის წინ
S&P 500 Correction Deepens as Investors Watch for Signs of a Market Bottom
The Motley Fool
·
6 საათის წინ
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Beinsure
·
20 საათის წინ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
JournalArta
·
45 წუთის წინ
S&P 500 Falls Into Correction as AI Spending Worries Grow
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc